Clinical Trial: Efficacy and Safety of Dual-Effect Myopia Control Lenses for Slowing Myopia Progression: A Single-Center, Randomized, Controlled, Noninferiority Trial

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934615) titled 'Efficacy and Safety of Dual-Effect Myopia Control Lenses for Slowing Myopia Progression: A Single-Center, Randomized, Controlled, Noninferiority Trial' on Nov. 08.

Brief Summary: This study aims to evaluate the efficacy and safety of dual-effect myopia control spectacle lenses in slowing myopia progression compared with Nikon MyoEase 2.0 lenses in children aged 8-13 years.

This is a single-center, randomized, open-label, parallel-group, noninferiority clinical trial. A total of 194 children with myopia will be randomly assigned in a 1:1 ratio to wear either dual-effect myopia control spectacle lenses or Nikon MyoEase 2.0 lenses for...